Evaluation of HLA-G immune checkpoint molecule in melanocytic lesions
ABSTRACT The human leukocyte antigen-G (HLA-G) is a non-classical molecule of the major histocompatibility complex. HLA-G has been associated with the process of tumorigenesis and tumor escape. In this study, we aim to evaluate the HLA-G expression in melanocytic lesions and in melanoma for determining when melanocytic lesions start its expression. Twenty-two skin biopsies samples were submitted to immunohistochemistry; HLA-G expression was detected in 63.6% of the samples. This expression in melanocytic cells was significantly higher in melanoma than in benign melanocytic lesions (p < 0.002). Our results suggest that HLA-G expression starts late in the process of tumorigenesis.
Saved in:
Main Authors: | Gomes,Raylane P, Caetano,Gabriela Tayrine, Sampaio,Lucas Henrique F, Silva,Camila R, Costa,Maurício B, Cysneiro,Maria Auxiliadora, Wastowski,Isabela Jubé |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Patologia Clínica
2020
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-24442020000100600 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The human leukocyte antigen G molecule (HLA-G) expression in patients with nasal polyposis
by: Avelino,Melissa Ameloti Gomes, et al.
Published: (2014) -
Inflammatory Infiltrates in Melanocytic Lesions
by: Relan,Alisha, et al.
Published: (2021) -
Predictive biomarkers of response to immune checkpoint inhibitors
by: Díaz-Carrasco,María Sacramento, et al.
Published: (2020) -
Nephrotoxicity in patients receiving immune checkpoint inhibitors
by: Chuva,Teresa
Published: (2019) -
Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor
by: Rocha,Marta, et al.
Published: (2019)